Evaluation of a Partial Ban on Rx‐Rebates in Germany

Maximilian M. Gail, Georg Götz, Daniel Herold, Jan T. Schäfer

Open source

DOI
10.1002/hec.70112
Published
2026-05-18
Container
Health Economics
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/hec.70112,
  title = {Evaluation of a Partial Ban on Rx‐Rebates in Germany},
  author = {Maximilian M. Gail and Georg Götz and Daniel Herold and Jan T. Schäfer},
  year = {2026},
  journal = {Health Economics},
  doi = {10.1002/hec.70112},
  url = {https://doi.org/10.1002/hec.70112}
}

RIS

TY  - JOUR
TI  - Evaluation of a Partial Ban on Rx‐Rebates in Germany
AU  - Maximilian M. Gail
AU  - Georg Götz
AU  - Daniel Herold
AU  - Jan T. Schäfer
PY  - 2026
JO  - Health Economics
DO  - 10.1002/hec.70112
UR  - https://doi.org/10.1002/hec.70112
ER  - 

APA

Gail, M. M., Götz, G., Herold, D., & Schäfer, J. T. (2026). Evaluation of a Partial Ban on Rx‐Rebates in Germany. Health Economics. https://doi.org/10.1002/hec.70112

Source records